Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4015 results

Sort By:

Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype

Study ID: NCT06863402
Start Date: 2026-04-15
End Date: 2030-04-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

32

Intervention / Treatment

Biospecimen Collection

Bone Marrow Biopsy

Computed Tomography

Echocardiography

Multigated Acquisition Scan

Nemtabrutinib

Pembrolizumab

Positron Emission Tomography

Administration Questionnaire

Sponsor

Roswell Park Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Effect of E-learning Training on National Institutes of Health Stroke Scale (NIHSS) and Modified Rankin Scale (mRS) Assessment

Study ID: NCT07318376
Start Date: 2026-04
End Date: 2026-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Educational intervention

Sponsor

Stuby Loric

Source: clinicaltrials.gov

Share:
Add to list

Behavioural Intervention to Decrease Exposure to Emerging Chemical Pollutants

Study ID: NCT07465315
Start Date: 2026-05
End Date: 2027-02
Study Type

Interventional

Study Phase

Phase3

No. of Participants

740

Intervention / Treatment

Guidelines from the public healthcare system

INPOL healthy lifestyle informative guidelines

Sponsor

University of Granada

Source: clinicaltrials.gov

Share:
Add to list

Study Evaluating the Efficacy and Safety of the Addition of Ivosidenib to Oral Azacitidine (Onureg®) in Patients Over 55 With Acute Myeloid Leukemia (AML) and IDH1 Mutation, in Complete Remission After Intensive Chemotherapy.

Study ID: NCT07463768
Start Date: 2026-09
End Date: 2030-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Ivosidenib + oral azacitidine

Sponsor

French Innovative Leukemia Organisation

Source: clinicaltrials.gov

Share:
Add to list

Coronary Sinus Reducer Therapy for Persisting Angina

Study ID: NCT07485985
Start Date: 2026-04-01
End Date: 2028-07-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

Coronary sinus reducer

Sponsor

UMC Utrecht

Source: clinicaltrials.gov

Share:
Add to list

Alpha/Beta T-cell Depleted Blood-forming Stem Cell Transplant From Related or Unrelated Donors for Blood Diseases in Children and Young Adults

Study ID: NCT04806347
Start Date: 2026-04
End Date: 2030-05
Study Type

Interventional

Study Phase

Phase1

No. of Participants

12

Intervention / Treatment

TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft

CliniMACS® System

Sponsor

University of Wisconsin, Madison

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Study of ZL-85FA Tablets

Study ID: NCT07339748
Start Date: 2026-06-30
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

51

Intervention / Treatment

ZL-85FA tablets

ZL-85FA tablets

ZL-85FA tablets

ZL-85FA tablets

ZL-85FA tablets

ZL-85FA tablets

ZL-85FA tablets

ZL-85FA tablets

ZL-85FA tablets

Sponsor

Chengdu Zenitar Biomedical Technology Co., Ltd

Source: clinicaltrials.gov

Share:
Add to list

A Prospective Observational Clinical Study on Exploring the Value of Surgical Excision Combined With 32P Application in the Treatment of Keloids and the Factors Affecting the Prognosis of Combined Therapy

Study ID: NCT07413497
Start Date: 2026-06-01
End Date: 2030-06-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

401

Intervention / Treatment
Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Source: clinicaltrials.gov

Share:
Add to list

Allopregnanolone in Chronic Complex Traumatic Brain Injury

Study ID: NCT04003285
Start Date: 2026-06-01
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

132

Intervention / Treatment

Placebo

Allopregnanolone

Allopregnanolone

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Feasibility of Real-Time Visual Feedback in Augmented Reality to Reduce Gait Asymmetry Post-Stroke

Study ID: NCT07178535
Start Date: 2026-04-15
End Date: 2027-09-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Feasibility of Two Types of Real-Time Visual Feedback in an Augmented Reality

Sponsor

McGill University

Source: clinicaltrials.gov

Share:
Add to list